Correction: Exploration of Novel Inhibitors for Class I Histone Deacetylase Isoforms by QSAR Modeling and Molecular Dynamics Simulation Assays.

Correction: Exploration of Novel Inhibitors for Class I Histone Deacetylase Isoforms by QSAR Modeling and Molecular Dynamics Simulation Assays.

Bibliographic Details
Main Authors:	Zainab Noor, Noreen Afzal, Sajid Rashid
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2015-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC4642989?pdf=render

Similar Items

Exploration of Novel Inhibitors for Class I Histone Deacetylase Isoforms by QSAR Modeling and Molecular Dynamics Simulation Assays.
by: Zainab Noor, et al.
Published: (2015-01-01)

Histone Deacetylases and Their Isoform-Specific Inhibitors in Ischemic Stroke
by: Svetlana Demyanenko, et al.
Published: (2021-10-01)

QSAR and molecular docking study on the biological activity of levofloxacin and thiodiazole histone deacetylase inhibitors
by: Zhong Wan, et al.
Published: (2020-01-01)

Histone Deacetylases and Histone Deacetylase Inhibitors in Neuroblastoma
by: Monica Phimmachanh, et al.
Published: (2020-10-01)

Histone Deacetylases and Histone Deacetylase Inhibitors: Molecular Mechanisms of Action in Various Cancers
by: Masumeh Sanaei, et al.
Published: (2019-01-01)

Histone deacetylase inhibitors
by: Marzena Baran, et al.
Published: (2020-08-01)

Molecular modeling study on tunnel behavior in different histone deacetylase isoforms.
by: Sundarapandian Thangapandian, et al.
Published: (2012-01-01)

Structure-Based Inhibitor Discovery of Class I Histone Deacetylases (HDACs)
by: Yuxiang Luo, et al.
Published: (2020-11-01)

Histone deacetylase inhibitors in multiple myeloma
by: Sarah Deleu, et al.
Published: (2009-06-01)

Antidepressant Actions of Histone Deacetylase Inhibitors
by: Haggarty, Stephen J., et al.
Published: (2010)

Medicinal chemistry of histone deacetylase inhibitors
by: Ružić Dušan, et al.
Published: (2021-01-01)

The application of histone deacetylases inhibitors in glioblastoma
by: Rui Chen, et al.
Published: (2020-07-01)

Histone Deacetylases and their Inhibitors in Cancer Epigenetics
by: Kelly N. Hassell
Published: (2019-11-01)

The therapeutic potential of class I selective histone deacetylase inhibitors in ovarian cancer
by: Dineo eKhabele
Published: (2014-05-01)

Continuous enzyme activity assay for high-throughput classification of histone deacetylase 8 inhibitors
by: Markus Schweipert, et al.
Published: (2023-06-01)

Discovery of novel polysubstituted N-alkyl acridone analogues as histone deacetylase isoform-selective inhibitors for cancer therapy
by: Ze Wang, et al.
Published: (2023-12-01)

Histone Deacetylase Inhibitors from Marine Invertebrates
by: Claudio Luparello, et al.
Published: (2020-11-01)

Roles of Histone Deacetylases and Inhibitors in Anticancer Therapy
by: Flávia Alves Verza, et al.
Published: (2020-06-01)

Histone Deacetylase (HDAC) Inhibitors for the Treatment of Schistosomiasis
by: Ehab Ghazy, et al.
Published: (2022-01-01)

The Impact of Fluorination on the Design of Histone Deacetylase Inhibitors
by: Duong Tien Anh, et al.
Published: (2023-02-01)

Histone Deacetylase Inhibitors and Diabetic Kidney Disease
by: Mitchell J. Hadden, et al.
Published: (2018-09-01)

The effect of histone deacetylase inhibitors on AHSP expression.
by: Mohammad Ali Okhovat, et al.
Published: (2018-01-01)

Attenuation of choroidal neovascularization by histone deacetylase inhibitor.
by: Nymph Chan, et al.
Published: (2015-01-01)

Dual Inhibitors Targeting DNA and Histone Deacetylases
by: Chen Chen, et al.
Published: (2020-06-01)

Zinc binding groups for histone deacetylase inhibitors
by: Lei Zhang, et al.
Published: (2018-01-01)

Antitheilerial Activity of the Anticancer Histone Deacetylase Inhibitors
by: Madhumanti Barman, et al.
Published: (2021-11-01)

Molecular mechanisms of histone deacetylases and inhibitors in renal fibrosis progression
by: Jiayu Wang, et al.
Published: (2022-09-01)

Histone Deacetylase Expressions in Hepatocellular Carcinoma and Functional Effects of Histone Deacetylase Inhibitors on Liver Cancer Cells In Vitro
by: Kim Freese, et al.
Published: (2019-10-01)

Statins and Histone Deacetylase Inhibitors Affect Lamin A/C – Histone Deacetylase 2 Interaction in Human Cells
by: Elisabetta Mattioli, et al.
Published: (2019-01-01)

Quantification of histone deacetylase isoforms in human frontal cortex, human retina, and mouse brain.
by: Kyle W Anderson, et al.
Published: (2015-01-01)

Differential effects of class I isoform histone deacetylase depletion and enzymatic inhibition by belinostat or valproic acid in HeLa cells
by: Dejligbjerg Marielle, et al.
Published: (2008-09-01)

Epigenetic therapies in acute myeloid leukemia: the role of hypomethylating agents, histone deacetylase inhibitors and the combination of hypomethylating agents with histone deacetylase inhibitors
by: Qing-Yu Xu, et al.
Published: (2020-03-01)

Histone deacetylases and their inhibitors: molecular mechanisms and therapeutic implications in diabetes mellitus
by: Xiaojie Wang, et al.
Published: (2012-08-01)

Histone Acetyltransferase and Deacetylase Inhibitors—New Aspects and Developments
by: Hany S. Ibrahim, et al.
Published: (2023-11-01)

Histone Deacetylase Inhibitors and Phenotypical Transformation of Cancer Cells
by: Anna Wawruszak, et al.
Published: (2019-01-01)

HDACiDB: a database for histone deacetylase inhibitors
by: Murugan K, et al.
Published: (2015-04-01)

Potential of histone deacetylase inhibitors for the therapy of ovarian cancer
by: Fengyi Guo, et al.
Published: (2022-11-01)

Enhancing the anti-angiogenic action of histone deacetylase inhibitors
by: Dwarte Tanya, et al.
Published: (2007-10-01)

Screening of selective histone deacetylase inhibitors by proteochemometric modeling
by: Wu Dingfeng, et al.
Published: (2012-08-01)

Tetrahydroisoquinolines as novel histone deacetylase inhibitors for treatment of cancer
by: Danqi Chen, et al.
Published: (2016-01-01)